Skip Navigation

A Phase I, First-in-Human Study of MEN2312, a KAT6 inhibitor, as Monotherapy and in Combination in Participants with Advanced Breast Cancer

Brief Summary

Type:
Breast Cancer

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT06638307

Study #:
STUDY00162068

Start Date:
May 29, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06638307

View Complete Trial Details & Eligibility at ClinicalTrials.gov